These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Savitz SI; Cramer SC; Wechsler L; Stroke; 2014 Feb; 45(2):634-9. PubMed ID: 24368562 [No Abstract] [Full Text] [Related]
3. Stem cells for enhancing recovery after stroke: a review. England T; Martin P; Bath PM Int J Stroke; 2009 Apr; 4(2):101-10. PubMed ID: 19383051 [TBL] [Abstract][Full Text] [Related]
4. Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell. Sarmah D; Kaur H; Saraf J; Pravalika K; Goswami A; Kalia K; Borah A; Wang X; Dave KR; Yavagal DR; Bhattacharya P Transl Stroke Res; 2018 Aug; 9(4):356-374. PubMed ID: 29075984 [TBL] [Abstract][Full Text] [Related]
5. Stem cell therapy in stroke treatment: is it a viable option? Mir O; Savitz SI Expert Rev Neurother; 2013 Feb; 13(2):119-21. PubMed ID: 23368796 [No Abstract] [Full Text] [Related]
6. Stroke repair with cell transplantation: neuronal cells, neuroprogenitor cells, and stem cells. Kondziolka D; Wechsler L Neurosurg Focus; 2008; 24(3-4):E13. PubMed ID: 18341389 [TBL] [Abstract][Full Text] [Related]
7. Stem cell therapy for human neurodegenerative disorders-how to make it work. Lindvall O; Kokaia Z; Martinez-Serrano A Nat Med; 2004 Jul; 10 Suppl():S42-50. PubMed ID: 15272269 [TBL] [Abstract][Full Text] [Related]
8. Stem cells in stroke treatment: the promise and the challenges. Sinden JD; Muir KW Int J Stroke; 2012 Jul; 7(5):426-34. PubMed ID: 22712742 [TBL] [Abstract][Full Text] [Related]
13. Taking stock and planning for the next decade: realistic prospects for stem cell therapies for the nervous system. Snyder EY; Daley GQ; Goodell M J Neurosci Res; 2004 Apr; 76(2):157-68. PubMed ID: 15048913 [TBL] [Abstract][Full Text] [Related]
14. Biological restoration of central nervous system architecture and function: part 3-stem cell- and cell-based applications and realities in the biological management of central nervous system disorders: traumatic, vascular, and epilepsy disorders. Farin A; Liu CY; Langmoen IA; Apuzzo ML Neurosurgery; 2009 Nov; 65(5):831-59; discussion 859. PubMed ID: 19834396 [TBL] [Abstract][Full Text] [Related]
15. Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered. Napoli E; Borlongan CV Stem Cell Rev Rep; 2017 Apr; 13(2):192-197. PubMed ID: 28064388 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic management of ischemic stroke: relevance to stem cell therapy. Gilman S Exp Neurol; 2006 May; 199(1):28-36. PubMed ID: 16631744 [TBL] [Abstract][Full Text] [Related]
17. Clinical trials of stroke therapy: which cells, which patients? Wechsler LR Stroke; 2009 Mar; 40(3 Suppl):S149-51. PubMed ID: 19064792 [No Abstract] [Full Text] [Related]
18. Blood-based biomarkers and stem cell therapy in human stroke: a systematic review. PalĂ E; Bustamante A; Jolkkonen J; Hommel M; Rosell A; Montaner J Mol Biol Rep; 2020 Aug; 47(8):6247-6258. PubMed ID: 32638318 [TBL] [Abstract][Full Text] [Related]
19. Integration and translation: driving stem cell therapies toward the clinic. Trounson A Regen Med; 2008 May; 3(3):269-73. PubMed ID: 18462051 [No Abstract] [Full Text] [Related]
20. Human trials for neurodegenerative disease. Kelly CM; Handley OJ; Rosser AE Methods Mol Biol; 2009; 549():33-47. PubMed ID: 19378194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]